Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era

PURPOSE: The long-term risk of prostate cancer–specific mortality (PCSM) after radical prostatectomy is poorly defined for patients treated in the era of widespread prostate-specific antigen (PSA) screening. Models that predict the risk of PCSM are needed for patient counseling and clinical trial de...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Stephenson, Andrew J., Kattan, Michael W., Eastham, James A., Bianco, Fernando J., Yossepowitch, Ofer, Vickers, Andrew J., Klein, Eric A., Wood, David P., Scardino, Peter T.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Clinical Oncology 2009
Θέματα:
Original Reports
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3651598/
https://ncbi.nlm.nih.gov/pubmed/19636023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.2501
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια